Olema Pharmaceuticals

Company snapshot

Olema Pharmaceuticals is a pharma organization headquartered in Chennai, IN. It trades on NYSE under ticker OLMA. Primary therapeutic focus areas include Hormone Receptor Positive Breast Carcinoma, ER+, HER2- Advanced Breast Cancer, Advanced or Metastatic Solid Tumors, Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Breast Cancer. NovaPharmaNews links 7 clinical program(s), 0 drug profile(s), and 8 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (3), phase 1 (3), phase 2 (1).

• 7 active pipeline program(s) linked via ClinicalTrials.gov.
• 8 US patent(s) indexed to this assignee profile.
• 7 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Olema Pharmaceuticals. Not investment advice.

• Peer + 0 momentum

  Eli Lilly and

  TA overlap score 32.4

• Peer + 0 momentum

  Oncolytics Biotech

  TA overlap score 24.6

• Peer + 0 momentum

  Quantum Pharmaceuticals

  TA overlap score 23.6

• Peer + 0 momentum

  Context Therapeutics

  TA overlap score 21.6

Recent activity

Latest pipeline, patent, and corporate events for Olema Pharmaceuticals.

1. Jun 8, 2026 Clinical update

   OP-1250-301 — Phase 3

2. Jun 8, 2026 Clinical update

   OP-1250-302 — Phase 3

3. Jun 8, 2026 Clinical update

   Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors — Phase 1

4. May 26, 2026 Clinical update

   OP-1250 — Phase 2

5. May 23, 2026 Clinical update

   Palazestrant — Phase 3

View all clinical trial activity →

• What is Olema Pharmaceuticals?

  Olema Pharmaceuticals is a pharma organization headquartered in Chennai, IN. It trades on NYSE under ticker OLMA. Primary therapeutic focus areas include Hormone Receptor Positive Breast Carcinoma, ER+, HER2- Advanced Breast Cancer, Advanced or Metastatic Solid Tumors, Advanced o

• Is Olema Pharmaceuticals publicly traded?

  Yes. Olema Pharmaceuticals is listed with ticker OLMA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Olema Pharmaceuticals develop or market?

  We link 17 drug profile(s) where Olema Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/olema-pharmaceuticals#company-drugs.

• What are the latest developments for Olema Pharmaceuticals?

  In the last 12 months our linked public records show 7 trial program update(s) and 2 US patent grant(s) tied to this profile.

• What therapeutic areas does Olema Pharmaceuticals focus on?

  Olema Pharmaceuticals focuses on Hormone Receptor Positive Breast Carcinoma, ER+, HER2- Advanced Breast Cancer, Advanced or Metastatic Solid Tumors based on our analysis of their pipeline programs and drug development activities.